Online Exclusives

Online Exclusives

Europe’s CHMP Recommends Ixazomib for Multiple Myeloma

Europe’s Committee for Medicinal Products for Human Use (CHMP) recommended approval for ixazomib in combination with lenalidomide and dexamethasone for patients with multiple myeloma...

Conference Coverage: Updates on Idelalisib in CLL and FL: Superior PFS and Durable Responses

CHICAGO—Two posters presented at the 2015 ASCO Annual Meeting provided encouraging data for the use of the pi3k delta inhibitor idelalisib in the treatment...

European Commission Approves Lenalidomide for Relapsed/Refractory Mantle Cell Lymphoma

The European Commission approved lenalidomide for the treatment of adult patients with relapsed/refractory mantle cell lymphoma (MCL), following a recommendation earlier this year from...

National Institutes of Health Funds Study of Zika Virus Exposure in Olympic Athletes

The National Institutes of Health’s (NIH) Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) is funding a research initiative to...

FDA Grants Fast-Track Designation to Tazemetostat for DLBCL

The U.S. Food and Drug Administration granted fast-track designation to tazemetostat for patients with relapsed/refractory diffuse large B-cell lymphoma with EZH2-activating mutations. Tazemetostat is...

Letermovir Meets Primary Endpoint in Phase III Trial for Cytomegalovirus Prevention

In a global, multicenter, randomized, placebo-controlled, phase III clinical trial evaluating the safety and efficacy of letermovir, the investigational antiviral medication prevented clinically significant...

From ASH 2014: Promising Phase 2 Results with ACE-536 in β-Thalassemia

SAN FRANCISCO — ACE-536, a recombinant fusion protein containing modified activin receptor type IIB and IgG Fc, has shown promising results in the treatment...

From ASH 2014: AHCT Should Be Standard of Care for HIV-Associated Lymphoma

SAN FRANCISCO — Results from a multi-institutional trial presented at ASH 2014 debunk common myths that HIV-positive patients with lymphoma might not be suitable for...

American Society of Hematology Releases Statement on Congressional Funding

The American Society of Hematology (ASH) released a statement from President Charles S. Abrams, MD, congratulating Congress on the passage of a short-term resolution to fund...

Donor Age and Sex May Affect Outcomes for Patients Receiving Red Blood Cell Transfusions

According to a study published in JAMA Internal Medicine, red blood cell (RBC) transfusions from donors who are younger or female are associated with...
Advertisement

Current Issue

May 2021 Volume 7 Issue 6

This issue provides an update on gene therapies in hematology, demystifies RNA sequencing, and more.

Block title